Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Neuropharmacology. 2021 Oct 4;200:108820. doi: 10.1016/j.neuropharm.2021.108820

Figure 1.

Figure 1.

Potency of MDPV in inhibiting DA-induced Ca2+ signals at hDAT and dDAT. Stable cell lines expressing hDAT or dDAT were transfected with CaV1.2 and auxiliary subunits. Intracellular Ca2+ signals were determined using fluorescence microscopy under constant perfusion at 35°C in Fura2-AM loaded cells. A) Ca2+ signals showing the inhibitory effect of MDPV at different concentrations at hDAT, the traces are normalized to the first DA pulse, each trace is mean ± SEM of N ≥ 59 cells analyzed per MDPV concentration. B) Traces showing the inhibitory effect of MDPV at dDAT, the traces are normalized to the first DA pulse, each trace is mean ± SEM of N ≥ 77 cells analyzed per MDPV concentration. C) Dose-response curves obtained from the data shown in A and B. Since MDPV was quite weak at dDAT, the bottom of the curve fitting was constrained to zero to estimate the pIC50. The fitting parameters for MDPV inhibition at hDAT and dDAT are included in Table 2.